CSIMarket
 


Asensus Surgical Inc   (ASXC)
Other Ticker:  
 
 

ASXC's Net Cash Flow Growth by Quarter and Year

Asensus Surgical Inc 's Net Cash Flow results by quarter and year




ASXC Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -7.51 -41.65 -3.59
III Quarter September 14.26 2.84 -97.19 4.89
II Quarter June -10.85 -13.87 -8.27 -6.51
I Quarter March 12.41 6.72 148.87 12.17
FY   15.82 -11.82 1.76 6.96



ASXC Net Cash Flow third quarter 2023 Y/Y Growth Comment
Asensus Surgical Inc achieved in the third quarter 2023, above Company average Net Cash Flow surge of 401.94% year on year, to $ 14.26 millions.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 12 other companies have achieved higher Net Cash Flow growth. While Asensus Surgical Inc ' s Net Cash Flow doubling of 401.94% ranks overall at the positon no. 153 in the third quarter 2023.




ASXC Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September 401.94 % - - -
II Quarter June - - - -
I Quarter March 84.67 % -95.49 % 1123.25 % -
FY   - - -74.71 % -

Financial Statements
Asensus Surgical Inc 's third quarter 2023 Net Cash Flow $ 14.26 millions ASXC's Income Statement
Asensus Surgical Inc 's third quarter 2022 Net Cash Flow $ 2.84 millions Quarterly ASXC's Income Statement
New: More ASXC's historic Net Cash Flow Growth >>


ASXC Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - -74.71 % -




Net Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #13
Healthcare Sector #26
Overall #153

Net Cash Flow Y/Y Growth Statistics
High Average Low
1122.81 % 153.45 % -100 %
(Mar 31 2021)   (Jun 30 2017)
Net Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #13
Healthcare Sector #26
Overall #153
Net Cash Flow Y/Y Growth Statistics
High Average Low
1122.81 % 153.45 % -100 %
(Mar 31 2021)   (Jun 30 2017)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Asensus Surgical Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ASXC's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2023Seasonal Asensus Surgical Inc in the influence net cash outflow of $ 14.26 millionsSeasonal influence appear to have led to Asensus Surgical Inc 's return to profitability, as ASXC clinchesNet Cash Flow of $ 14.26 millions in the III. Quarter 2023 coming of net cash outflow-10.85 millions in the second quarter. Asensus Surgical Inc announced in the III. Quarter 2023 Net Cash Flow of $ 14.26 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Asensus Surgical Inc achieved highest sequential Net Cash Flow growth. While Asensus Surgical Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ASXC's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2023Seasonal Asensus Surgical Inc in the influence net cash outflow of $ 14.26 millionsSeasonal influence have led to Asensus Surgical Inc 's rebound to profitability, as ASXC clinchesNet Cash Flow of $ 14.26 millions in the III. Quarter 2023 emanate net cash outflow-10.85 millions in the second quarter. Asensus Surgical Inc announced in the III. Quarter 2023 Net Cash Flow of $ 14.26 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Asensus Surgical Inc achieved highest sequential Net Cash Flow growth. While Asensus Surgical Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Asensus Surgical Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ 8.31 $ -3.11 $ -6.13 $ -11.81 $ -45.96
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
Asensus Surgical Inc saw improvement in Net Cash Flow growth trend, posting cumulative 12 months Net Cash Flow growth of 401.94% year on year, to $ 8 millions if the fiscal year would have ended in Sep 30 2023.
Asensus Surgical Inc 's trailing twelve months Net Cash Flow growth was higher than company's average 0% and higher than % growth in Jun 30 2023. And, Asensus Surgical Inc realized the fastest Net Cash Flow growth, in Medical Equipment & Supplies industry. In the Sep 30 2023 period, Asensus Surgical Inc had cumulative twelve months Net Cash Flow of $ 8 millions compare to net cash outflow of $ -46 millions a year ago.

Asensus Surgical Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Asensus Surgical Inc saw improvement in Net Cash Flow growth trend, posting cumulative 12 months Net Cash Flow growth of 401.94% year on year, to $ 8 millions if the fiscal year would have ended in Sep 30 2023.
Asensus Surgical Inc 's trailing twelve months Net Cash Flow growth was higher than company's average 0% and higher than % growth in Jun 30 2023. And, Asensus Surgical Inc realized the fastest Net Cash Flow growth, in Medical Equipment & Supplies industry. In the Sep 30 2023 period, Asensus Surgical Inc had cumulative twelve months Net Cash Flow of $ 8 millions compare to net cash outflow of $ -46 millions a year ago.

Asensus Surgical Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
ASXC's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for ASXC's Competitors
Net Cash Flow Growth for Asensus Surgical Inc 's Suppliers
Net Cash Flow Growth for ASXC's Customers

You may also want to know
ASXC's Annual Growth Rates ASXC's Profitability Ratios ASXC's Asset Turnover Ratio ASXC's Dividend Growth
ASXC's Roe ASXC's Valuation Ratios ASXC's Financial Strength Ratios ASXC's Dividend Payout Ratio
ASXC's Roa ASXC's Inventory Turnover Ratio ASXC's Growth Rates ASXC's Dividend Comparisons



Companies with similar Net Cash Flow doubling for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2023
Edwards Lifesciences Corporation650.82%$ 650.820 millions
Xtant Medical Holdings Inc 468.92%$ 468.915 millions
Xencor Inc467.23%$ 467.232 millions
Merus N v 418.61%$ 418.606 millions
Asensus Surgical Inc 401.41%$ 401.407 millions
Forte Biosciences Inc 368.13%$ 368.127 millions
Qrons Inc 343.36%$ 343.363 millions
Vericel Corporation327.94%$ 327.938 millions
Mirati Therapeutics Inc 287.63%$ 287.630 millions
Envista Holdings Corporation279.96%$ 279.956 millions
Repligen Corp271.45%$ 271.446 millions
Iovance Biotherapeutics Inc 266.44%$ 266.437 millions
Orasure Technologies Inc249.29%$ 249.293 millions
Teladoc Health Inc 228.82%$ 228.824 millions
Immunitybio inc 218.18%$ 218.182 millions
Axogen inc 205.37%$ 205.366 millions
Amarin Corp Plcuk202.58%$ 202.576 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com